Alto Neuroscience, Inc. Common Stock (ANRO)

Other Income/Expenses (Net)

$1.49M

Quarterly · Period ending: · USD

ANRO logo

ANRO Other Income/Expenses (Net)

Latest reported$1.49M
ANRO Quarterly Other Income/Expenses (Net) ($408.00K → $1.49M)
High-resolution chart · PNG

ANRO other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Alto Neuroscience, Inc. Common Stock Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
1,491,000
901,000
-131,855,000
770,000
976,000
507,000
1,796,000
2,103,000
2,311,000
969,000
548,000
577,000
462,000
-83,000
408,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.